1. Introduction {#sec1}
===============

Preeclampsia (PE) is defined as the onset of hypertension and proteinuria after 20 weeks of gestation in previously normotensive nonproteinuric pregnant women. This syndrome is a leading cause of maternal and fetal morbidity and mortality \[[@B1]\]. The etiology of this disorder is not known. Poor placental perfusion along with the endothelial cell dysfunction and a disturbed balance of angiogenic factors may all contribute to this disorder. Poor placental perfusion is a stimulus of reactive oxygen species (ROS) production. It is believed that the latter has a critical role in the manifestations and complications of PE \[[@B2]\].

In contrast to normal pregnancy, preeclampsia is characterized by generalized vasoconstriction, increased systemic vascular resistance, increased pressor response to vasoconstrictor agonists such as angiotensin II, endothelin, thromboxane, and widespread vascular endothelial damage \[[@B3]\].

To study the various aspects of PE, several animal models have been proposed \[[@B4]\]. One of the most popular models is administration of *N* (G)-nitro-L-arginine methyl ester (L-NAME) as a nitric oxide synthase (NOS) inhibitor during mid to late period of gestation of the animal (usually rat). NOS inhibition results in pathological changes similar to those observed in women with preeclampsia, such as hypertension, proteinuria, severe renal vasoconstriction, thrombocytopenia, and intrauterine growth retardation \[[@B5]\].

The present study was conducted to identify some mechanisms of vascular response changes in experimental PE model. Moreover, to investigate the role of oxidative stress in these changes, the effect of tempol, a synthetic antioxidant and a superoxide dismutase mimetic agent, was also studied. The used agents to clarify these alterations were phenylephrine (an alpha-adrenergic agonist), calcium (as an spasmogen which enters the cell via voltage-operated calcium channels), acetylcholine (endothelial NO releaser) and diazoxide (an ATP-dependent potassium channel opener).

2. Methods {#sec2}
==========

2.1. Animals {#sec2.1}
------------

Female *Sprague-Dawley* rats weighing 250--300 g were used. The animals were kept at controlled temperature (25°C) and 12 h light-12 h dark condition. They had free access to food and tap water (except after Day 10 of pregnancy in which the drinking water was modified as stated below). The female rats were mated at night with male *Sprague-Dawley* rats. Day 0 of pregnancy was defined as the day when the vaginal plaque was seen. On Day 10 of pregnancy, the rats were divided into five groups: group I consisted of normal pregnant animals that received only tap water. Rats in group II were treated with L-NAME 50 mg/kg/day dissolved in drinking water; rats in groups III, IV, and V were treated with L-NAME (50 mg/kg/day) plus tempol 20, 60, and 180 mg/kg/day, respectively. Both agents were administered through drinking water.

All the animal procedures were approved by the Ethics Committee of Shiraz University of Medical Sciences.

2.2. Drugs and Chemicals {#sec2.2}
------------------------

L-NAME was purchased from Alexis Biochemicals (USA). Tempol, phenylephrine, acetylcholine, diazoxide, 1,1,3,3-tetraethoxypropan (TEP), trichloroacetic acid (TCA), and thiobarbituric acid (TBA) were purchased from Sigma Chemical Company. 8-isoprostane ELISA kit was purchased from Cayman Chemical Company (Ann Arbor, MI, USA). All the chemicals used for preparation of physiological salt solution (PSS) were of analytical grade.

L-NAME and tempol were dissolved in animals\' drinking water. Phenylephrine and acetylcholine were dissolved in distilled water to make 10^−3 ^M stock solution. Diazoxide was dissolved in dimethyl sulfoxide (DMSO). Further dilutions were made by adding distilled water.

2.3. Measurement of Blood Pressure, Urine Protein, Plasma Malondialdehyde, and 8-Isoprostane {#sec2.3}
--------------------------------------------------------------------------------------------

Systolic blood pressure was measured in all groups on gestational Days 10, 13, 15, 18, and 21 by an automated sphygmomanometer with a tail-cuff device (ML 125/R, ADInstruments, Australia). Measuring was made on pretrained rats placed in a plexiglass restrainer. Ten measurements with 30 s intervals were done. The first three were ignored and the mean of the last seven reads was calculated.

To ensure about PE establishment, urine protein of group 1 (normal pregnant rats) and group 2 (pregnant rats received L-NAME) was assayed on Day 20 of gestation. To accomplish this, animals were placed in metabolic cages, 24 h urine was collected, and its protein content was measured based on Bradford method \[[@B6]\].

On gestational Day 20, the rats were sedated with ether, and a blood sample was taken via tail artery. Then it was centrifuged at 1000 g for 10 min and its plasma was collected and immediately frozen to −80°C until the day of analysis.

Plasma malondialdehyde (MDA), a lipid peroxidation end product, was assessed based on the reaction of thiobarbituric acid with MDA. Malondialdehyde (MDA) concentration was determined by comparison to a standard curve of TEP. Standard curve was made using serial dilution of TEP to yield the following test concentrations: 0, 1, 2, 2.5, 5, and 10 *μ*M. 0.5 mL of plasma or standard solutions was taken in a test tube and 2 mL of the TBA-TCA (TBA-TCA reagent: 0.375% w/v TBA, 15% w/v TCA, and 0.25 N HCl) solution were added. The mixture was heated in a water bath (90--100°C) for 15 min, cooled in a cold water bath for 10 min, and then centrifuged at 2000 g for 15 min. The absorbance of solution was read spectrophotometrically at 535 nm \[[@B7]\].

Plasma 8-isoprostane concentration was measured by an enzyme immunoassay kit according to the manufacturer\'s instructions.

2.4. Isolated Aorta Studies {#sec2.4}
---------------------------

On Day 22 of gestation, the animals were sacrificed under ether anesthesia. The thorax was opened. The thoracic aorta was removed carefully, placed in a Petri dish containing PSS and divided into four pieces of about 2-3 mm length. The endothelium of three aortic pieces was removed by rolling a fine needle (gauge 18) inside the vessel. The endothelium of one piece was left intact to investigate endothelium-dependent relaxation by acetylcholine. Each aortic ring was mounted between two parallel wires in a four-chamber organ bath at 37°C. The resting tension was adjusted to 0.5 g. The PSS contained (in mM) NaCl 118, KCl 4.8, KH~2~PO~4~ 1.2, CaCl~2~ 2.5, MgSO~4~ 1.2, NaHCO~3~ 25, and D-glucose 11. Its pH was adjusted to 7.4. The solution was bubbled with 95% O~2~/5% CO~2~ and changed every 10 min. The tension of the rings was recorded via a force transducer (K 30, Hugo Sachs Elektronik, Germany) and an amplifier (Transducer-Amplifier Module Type 705/1, Hugo Sachs Elektronik, Germany) on a PC software (HSE-ACAD, Hugo Sachs Electronik, Germany). The aortic rings were allowed to equilibrate for 1 hr.

To study the changes in sensitivity to alpha-adrenergic receptor agonists, the aortic ring was exposed to cumulative concentrations of phenylephrine. The pEC~50~ (negative logarithm of effective concentration which produced 50 percent of maximum response) and maximum response were calculated.

To investigate the state of voltage-dependent calcium channels, the tissue was incubated in high potassium (100 mM) calcium-free PSS for 60 minutes. The high-KCl depolarizing solution was prepared by equimolar substitution of NaCl with KCl. Thereafter, increasing concentrations of calcium were added to the organ bath and the pEC~50~ and maximum response were calculated.

To study the endothelial cells capability to release nitric oxide (NO), another aortic ring was contracted with submaximal concentration (60--70% of maximal response) of phenylephrine. After reaching the plateau, the tissue was treated with cumulative concentrations of acetylcholine. The pIC~50~ (negative logarithm of concentration at which the ring relaxed to 50% of its initial contraction) and maximum relaxation were calculated.

To study the responsiveness of vascular ATP-dependent potassium channels, another aortic ring was exposed to KCl (30 mM). When maximum tension was reached, cumulative concentrations of diazoxide were added to the organ bath and IC~50~ and maximum response were calculated.

2.5. Statistical Analysis {#sec2.5}
-------------------------

All the values were expressed as the mean ± SEM (standard error of the mean). Maximum contractile responses to phenylephrine and calcium were expressed as developed tension (g). Relaxation responses to acetylcholine and diazoxide were expressed as a percentage of relaxation of the maximum contractions. pEC~50~ and pIC~50~ values were calculated based on the best-fit method using Curve Expert software (Ver. 1.3). The data were analyzed using unpaired Student\'s *t*-test and analysis of variance (ANOVA) followed by a posthoc Dunnett test. Differences were considered to be statistically significant when *P* value was \< 0.05.

3. Results {#sec3}
==========

Before the administration of L-NAME, systolic blood pressure and 24-hour urine protein did not differ between normal and preeclamptic groups. The SBP was significantly higher (*P* \< 0.001) in the L-NAME treated group compared to the control group on Days 13, 15, 18 and 21 of gestation ([Figure 1](#fig1){ref-type="fig"}). The comparison also showed higher 24 hour urinary protein in the L-NAME treated group (5.29 ± 0.28 mg versus 3.66 ± 0.27 mg, *P* \< 0.001).

Tempol at 20 and 60 mg/kg doses significantly lowered SBP on Days 15, 18, and 21 in the preeclamptic rats. In contrast, the highest dose of tempol, that is, 180 mg/kg, had no significant effect on this parameter ([Figure 1](#fig1){ref-type="fig"}).

Plasma level of 8-isoprostane and MDA as indices of whole body oxidative stress was higher in the preeclamptic rats (*P* \< 0.001). Tempol treatment at doses 20 and 60 but not 180 mg/kg/day reduced the plasma concentration of MDA and 8-isoprostane ([Figure 2](#fig2){ref-type="fig"}).

The aortic rings of preeclamptic rats were more sensitive to the contractile effect of phenylephrine ([Table 1](#tab1){ref-type="table"}). However, there was no significant difference in phenylephrine-induced maximal tension between preeclamptic and normal rats ([Table 1](#tab1){ref-type="table"}). Aortic rings of tempol-treated preeclamptic rats (all 3 doses) showed significantly reduced sensitivity to phenylephrine ([Figure 3(a)](#fig3){ref-type="fig"}, [Table 1](#tab1){ref-type="table"}). The maximum phenylephrine-induced contraction was significantly lower in the preeclamptic animals treated by 20 and 60 mg/kg of tempol ([Table 1](#tab1){ref-type="table"}).

The contractile response of the aorta to calcium did not differ among groups ([Figure 3(b)](#fig3){ref-type="fig"}, [Table 1](#tab1){ref-type="table"}). However, calcium-induced maximum tension (and not its pEC~50~) in preeclamptic animals fed with tempol was remarkably higher than that of the preeclamptic controls, but statistically significant difference was only reached by the dose of 180 mg/kg ([Table 1](#tab1){ref-type="table"}).

The potency and maximal effect of acetylcholine to relax aortic rings precontracted by phenylephrine were lower in preeclamptic rats ([Figure 4(a)](#fig4){ref-type="fig"}, [Table 1](#tab1){ref-type="table"}). Aortic rings of preeclamptic animals treated by tempol 20 and 60 but not 180 mg/kg showed significantly higher sensitivity to acetylcholine compared to the preeclamptic controls. Also, the maximal acetylcholine-induced relaxation was significantly greater in animals receiving these doses ([Figure 4(a)](#fig4){ref-type="fig"}, [Table 1](#tab1){ref-type="table"}).

pIC~50~ and maximum relaxing effect of diazoxide on KCl-induced aortic contraction did not differ among the studied groups ([Figure 4(b)](#fig4){ref-type="fig"}, [Table 1](#tab1){ref-type="table"}).

4. Discussion {#sec4}
=============

In the present study, the action of tempol as a synthetic antioxidant on blood pressure and responsiveness to some vasodilators and vasoconstrictors is evaluated. Tempol can penetrate cell membranes and reacts with both intracellular and extracellular oxygen-free radicals \[[@B8]\]. These properties make tempol attractive for treatment of cardiovascular diseases associated with oxidative stress \[[@B9]\].

Administration of L-NAME from Day 10 of gestation induced two hallmarks of PE, that is, hypertension ([Figure 1](#fig1){ref-type="fig"}) and proteinuria. Also, plasma MDA and 8-isoprostane as markers of oxidative stress rose significantly in the L-NAME-treated pregnant rats ([Figure 2](#fig2){ref-type="fig"}). In pregnant rats, it was shown that treatment with L-NAME decreased plasma NO, prostacycline, and angiotensin II and increased plasma endothelin and thromboxane A2 \[[@B10]\]. It was also reported that hypertension induced by chronic NO deficiency is associated with increased oxidative stress \[[@B11], [@B12]\].

Tempol at doses of 20 and 60 mg/kg/day significantly reduced BP and plasma MDA and 8-isoprostane (Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). Tempol is a synthetic superoxide dismutase (SOD) mimetic agent. SOD catalyzes the conversion of O~2~^−^ to H~2~O~2~, which can be turned into water by catalase or the glutathione peroxidase system. Although SOD is the first-line physiological defense against oxidative stress, superoxide anions reaction with NO to form peroxynitrite, is threefold faster than their reaction with SOD which forms hydrogen peroxide \[[@B8]\]. Tempol potentiates antioxidant defense and may increase NO bioavailability. It has been reported that chronic tempol administration to hypertensive rats is accompanied by increased endothelium-dependent vasodilation \[[@B13]--[@B15]\]. Nevertheless, since in the present study the preeclamptic animals had been treated by L-NAME, a well-known NO synthesis inhibitor, rising NO level by tempol is questionable. So, the antihypertensive effect of tempol may be produced by NO-independent pathways. The effect of tempol on lowering hypertension and proteinuria in a genetic mouse model of preeclampsia has also been reported by Hoffmann et al. \[[@B16]\].

High dose tempol (180 mg/kg/day) decreased neither blood pressure nor markers of oxidative stress. A similar result has been reported by Preti et al. \[[@B17]\]. As stated above, tempol changes the highly reactive O~2~^−^ to H~2~O~2~. Although, H~2~O~2~ can contribute to the vasodilatory effects of tempol, H~2~O~2~ excess may induce vascular contraction \[[@B18], [@B19]\]. It is reported that a high concentration of H~2~O~2~ may inactivate NO \[[@B20]\].

Aortic rings of PE animals were more sensitive to the contractile effect of phenylephrine. However, maximum-induced contraction by this drug did not change in PE ([Figure 3(a)](#fig3){ref-type="fig"}, [Table 1](#tab1){ref-type="table"}). So, it seems that alpha-adrenergic receptors interaction with phenylephrine is changed in the experimental PE but the peak intracellular calcium increment or the interaction of contractile myofilaments is not. So, this change may be involved in the observed hypertension in PE animals. Aortic rings of tempol-treated PE animals show decreased sensitivity to phenylephrine. This effect can be seen even by tempol 180 mg/kg dose, a contradictory result with the observed effects of this dose on blood pressure and oxidative stress. We have no explanation for this discrepancy.

Entrance of calcium via calcium voltage operated channels and its effect on the contractile state did not change in L-NAME-induced PE ([Figure 3(b)](#fig3){ref-type="fig"}, [Table 1](#tab1){ref-type="table"}). So, it can be concluded that these channels have no role in PE hypertension. Also, the sensitivity of vascular contraction apparatus to calcium did not change in PE. Tempol administration to PE animals did not change the sensitivity of the vascular tissues to calcium. However, tempol at its highest dose significantly increased the maximum calcium-induced contraction.

The potency and maximum effect of acetylcholine to relax aortic rings were diminished significantly in PE rats ([Figure 4(a)](#fig4){ref-type="fig"}, [Table 1](#tab1){ref-type="table"}). This effect can be attributed to the oxidative stress in the endothelial cells which results in endothelial dysfunction. In our experiments, the animals had no access to L-NAME since the morning of the day of tissue studies. Moreover, after animal sacrifice, the aortic rings were held in PSS for about 2-3 hr. So, the studied vascular rings were free from the inhibitory effect of L-NAME on NO synthesis, and the above mentioned observation was due to the endothelial dysfunction produced by L-NAME administration during pregnancy. In accordance with the findings on blood pressure and oxidative stress, tempol treatment (20 and 60 mg/kg) improved the responses to acetylcholine in the preeclamptic rat aortas, denoting improvements in endothelial function in preeclamptic rats ([Figure 4(a)](#fig4){ref-type="fig"}, [Table 1](#tab1){ref-type="table"}). Decreased production and/or inactivation of superoxide anions by tempol can protect the endothelial cells, enhance the bioavailability of NO released from the endothelium, and mediate the beneficial effects of tempol on vascular reactivity in preeclamptic rats \[[@B21]--[@B25]\]. It has been reported that chronic tempol treatment of hypertensive rats is accompanied by increased endothelium-dependent vasodilation \[[@B13]--[@B15]\]. Tempol at high dose (180 mg/kg/day) did not improve the ACh relaxation in L-NAME treated rats. This observation is similar to the results obtained in blood pressure and oxidative stress and may have the similar basis.

The vasodilatory effect of diazoxide, an ATP-dependent potassium channel opener, on aortic rings of PE and normal pregnant rats was similar. So, in the experimental PE, vascular ATP-dependent potassium channels have no role in hemodynamic changes. It has been reported that endothelium-dependent hyperpolarizing factor (EDHF) action on the vascular tissue is diminished in PE \[[@B26]\]. It opens ATP-dependent potassium channels. Based on our results, it can be concluded that the decreased action of EDHF may be due to the reduction of its production, and ATP-potassium channel condition has no contribution to this reported observation.

In conclusion, in the experimental PE induced by L-NAME, blood pressure, oxidative stress markers, and the sensitivity of vascular tissue to contractile effects of alpha-adrenergic receptors are increased, and the endothelium-dependent relaxation by acetylcholine is decreased. Tempol at 20 and 60 mg/kg doses reverses the observed changes but in the dose of 180 mg/kg it has no effect.
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![Blood pressure of rats on Days 10 (before administration of any agents), 13, 15, 18, and 21 of gestation (*n* = 10--15). Each value represents mean ± SEM. Statistical comparisons were made between obtained value of each group with that of preeclamptic (L-NAME treated) group. \**P* \< 0.05; ^†^*P* \< 0.01; ^\#^*P* \< 0.001.](ISRN.PHARMACOLOGY2012-187208.001){#fig1}

![Concentrations of the plasma 8-isoprostane (a) and MDA (b) on Day 20 of gestation (*n* = 10--12). Each value represents mean ± SEM. Statistical comparisons were made between obtained value of each group with that of preeclamptic (L-NAME treated) group. ^\#^*P* \< 0.001.](ISRN.PHARMACOLOGY2012-187208.002){#fig2}

![Contractile responses of endothelium-denuded aortic rings of normal and preeclamptic (L-NAME treated) rats to phenylephrine (a) and calcium (b). Symbols represent means ± SEM of 8--10 experiments. For statistical analysis, see [Table 1](#tab1){ref-type="table"}.](ISRN.PHARMACOLOGY2012-187208.003){#fig3}

![Relaxation responses of aortic rings of normal and preeclamptic rats (L-NAME treated). (a) Vasorelaxant effect of acetylcholine on phenylephrine-induced contraction; (b) vasorelaxant effect of diazoxide on potassium (30 mM)-induced contraction. Symbols represent means ± SEM of 8--10 experiments. For statistical analysis, see [Table 1](#tab1){ref-type="table"}.](ISRN.PHARMACOLOGY2012-187208.004){#fig4}

###### 

The effect of studied agents on aortic rings of different groups of animals (*n* = 8--10). pEC50, the negative logarithm of the concentrations of phenylephrine and calcium which produced half of maximal contraction. pIC50, the negative logarithm of concentrations of acetylcholine and diazoxide which relaxed 50 percent of the initial contraction.

  Group                         Phenylephrine    Calcium        Acetylcholine   Diazoxide                                                  
  ----------------------------- ---------------- -------------- --------------- -------------- ----------------- ----------- ------------- ---------
  Normal                        7.06 ± 0.11^†^   660 ± 40       3.06 ± 0.04     270 ± 20       6.89 ± 0.11^\#^   86 ± 3^†^   5.03 ± 0.12   98 ± 1
  L-NAME (50 mg/kg)             7.61 ± 0.11      710 ± 40       3.12 ± 0.04     220 ± 20       5.93 ± 0.19       66 ± 5      4.90 ± 0.18   90 ± 4
  L-NAME + tempol (20 mg/kg)    6.94 ± 0.10^†^   360 ± 20^\#^   3.06 ± 0.09     320 ± 30       6.75 ± 0.25\*     87 ± 5^†^   5.03 ± 0.24   100 ± 0
  L-NAME + tempol (60 mg/kg)    6.82 ± 0.25^†^   440 ± 40^†^    3.11 ± 0.10     340 ± 20       6.99 ± 0.21^†^    91 ± 3^†^   4.92 ± 0.12   99 ± 1
  L-NAME + tempol (180 mg/kg)   7.08 ± 0.15\*    610 ± 50       3.24 ± 0.07     550 ± 50^\#^   5.77 ± 0.15       76 ± 5      4.70 ± 0.07   87 ± 3

Values are means ± SEM. \**P* \< 0.05; ^†^*P* \< 0.01; ^\#^*P* \< 0.001.
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